Skip to content

Thyroid Hormones Effect on Brown Adipose Tissue

Study on the Relationship Between the Thyroid Hormones and the Activity of Brown Adipose Tissue in Human

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01376648
Enrollment
20
Registered
2011-06-20
Start date
2009-12-31
Completion date
2012-05-31
Last updated
2011-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism

Brief summary

Brown adipose tissue (BAT) is important in energy expenditure through thermogenesis although the regulatory factors are not well known in humans. There is evidence suggesting that the thyroid hormones affect BAT functions in lower mammals, but the effects of the thyroid hormones on BAT activity in humans are still unclear. The objective of this study was to investigate the effects of thyroid hormones on glucose metabolism of BAT and other organs in humans.

Detailed description

Twenty consecutive patients with Graves'-caused hyperthyroidism who are newly diagnosed and untreated will be studied at the Endocrine Department of Huashan Hospital, Fudan University. All subjects are screened and examined by two senior investigators. Putative BAT activity is determined by the integrated 18F-fluorodeoxyglucose (18F-FDG) PET-CT. After the first PET scan, hyperthyroid patients will be treated with Methimazole following clinical guidelines. None of them uses beta adrenergic blockade. The initial dose of methimazole employed is 10mg thrice a day. During follow-up, the thyroid hormone levels (free triiodothyronine and free thyroxine) will be measured every twenty days. The PET-CT scans and assessments will be repeated when the symptoms have disappeared and the thyroid hormone levels return to normal range. Then the dose of methimazole will be adjusted accordingly.

Interventions

None listed

Sponsors

Huashan Hospital
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed and untreated hyperthyroid patients * Informed consent was obtained

Exclusion criteria

* History of other endocrine diseases * Useing beta adrenergic blockade * Pregnant women * Pacemaker implantation

Countries

China

Contacts

Primary ContactYiming Li, Dr.
yimingli@fudan.edu.cn862152888055

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026